Soticlestat (Standard)
Soticlestat (Standard) is the analytical standard of Soticlestat (HY-109123). This product is intended for research and analytical applications. Soticlestat (TAK-935; OV935) is a first-in-class, potent, selective, and orally active cholesterol 24-hydroxylase (CH24H) inhibitor. Soticlestat has the potential for epilepsy syndromes research.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 1429505-03-2
- Formule: C23H23N3O2
- Masse moléculaire:373.45
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-109123
SoticlestatCholesterol 24-hydroxylase Inhibitor -
HY-N2229
RhapontigeninCytochrome P450 1A1 Inactivator -
HY-B1232
Metyrapone11β-hydroxylase Inhibitor -
HY-103389
1-AminobenzotriazoleCytochrome P450 Inhibitor -
HY-14531
TalarozoleCYP26 Inhibitor/RAMBA -
HY-19340
TMSCYP1B1 Inhibitor -
HY-114759
MS-PPOHCYP Epoxygenase Inhibitor -
HY-N2229R
Rhapontigenin (Standard)Cytochrome P450 1A1 Inactivator -
HY-121188
DDMS20-HETE Inhibitor -
HY-101285
DMU2139CYP1B1 Inhibitor -
HY-B1232R
Metyrapone (Standard)11β-hydroxylase Inhibitor -
HY-14531R
Talarozole (Standard)CYP26 Inhibitor/RAMBA
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 1429505-03-2
-
Masse moléculaire 373.45
-
Formule C23H23N3O2
-
SMILES
O=C(N1CCC(CC2=CC=CC=C2)(O)CC1)C3=C(C4=CC=NC=C4)N=CC=C3
-
Synonyms
TAK-935 (Standard); OV935 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Toshiya Nishi, et al. Soticlestat, a novel cholesterol 24-hydroxylase inhibitor shows a therapeutic potential for neural hyperexcitation in mice. Sci Rep. 2020 Oct 13;10(1):17081. [Content Brief]
[2]. Krista Eschbach, et al. Stiripentol for the treatment of seizures in Dravet syndrome. Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Soticlestat (Standard) Related Classifications
HY-109123R Related Classifications
Powered by Bioz